Cancer Vaccine Institute News

Developing Vaccines to Create a New Standard of Care On October 22, 2025, the Cancer Vaccine Institute (CVI) at UW Medicine welcomed patients, advocates, researchers, and community members to DeLille Cellars in Woodinville, WA for an evening of connection and discovery. “Changing the Course of Ovarian Cancer” highlighted how cancer vaccines, once considered aspirational, are now changing lives and redefining what’s possible in cancer care. Driving a New Standard of Care The e

We are thrilled to announce that Dr. Natasha Hunter, MD, has been appointed Director of Clinical Trials at the Cancer Vaccine Institute (CVI). Dr. Hunter is a translational breast cancer researcher and clinical oncologist at the University of Washington and Fred Hutchinson Cancer Center. Her research focuses on circulating tumor DNA to guide treatment decisions and monitor disease response, as well as immunologic strategies to detect micrometastatic disease and prevent cancer

We are proud to announce that Dr. Nora Disis, Director of the Cancer Vaccine Institute, has been selected as a 2025 Champion of SITC by the Society for Immunotherapy of Cancer (SITC). This special recognition, part of SITC’s 40th anniversary celebration, honors 40 individuals whose work has significantly advanced the society’s mission—including education, scientific exchange, global access, advocacy, and leadership development. Dr. Disis’ pioneering contributions to cancer va

At the Cancer Vaccine Institute, we are proud to share a major milestone in our mission to develop safe and effective scalable cancer...

Every September, Ovarian Cancer Awareness Month reminds us of the urgent need to improve outcomes with a new standard of care for people...

On the Cancer Research Frontier is a series spotlighting the scientists, doctors, nurses, patients, and philanthropists at the CVI.

The Women’s University Club has selected Dr. Nora Disis , Cancer Vaccine Institute (CVI) Founder and Director, as one of three women in...

CVI Director Dr. Nora Disis was funded $300K to advance the development of a vaccine designed to prevent ovarian cancer’s metastatic spread.

Take a look at the Cancer Vaccine Institute's 2024 Year in Review.

At the Cancer Vaccine Institute at UW Medicine (CVI), we are dedicated to ending the most common and deadly cancers through innovative...

The Kuni Foundation presented their first Wayne Kuni Award for Innovation in Cancer Research to founding director Dr. Nora Disis.

On the Cancer Research Frontier is a series spotlighting the scientists, doctors, nurses, patients, and philanthropists at the CVI.

We are excited to reveal a polished rebrand that reflects our ongoing commitment to creating a world where cancer is treated and prevented.

Dr. Shaveta Vinayak shares publicly for the first time her journey from oncologist to oncology patient. 

CVI Founding Director Dr. Nora Disis receives a grant from the Breast Cancer Research Foundation to boost the progress of a cancer vaccine.

Dr. Nora Disis visits Spokane, Washington to share the progress and promise of cancer vaccines as a prevention and cure.

CVI Founder and Director Dr. Nora Disis was named 2024 UW Medicine's Inventor of the Year for her work on cancer vaccines.

CVI Executive Director Dr. Kiran Dhillon recounts her experience of being diagnosed with breast cancer and her drive to develop a treatment.

Dr. Nora Disis, CVI Founder and Director, was featured in the Wall Street Journal to discuss the hope and proress of cancer vaccines.

An in-depth look at cancer vaccines includes CVI Director Dr. Nora Disis and patient Bridgette Hempstead.